Israel Englander Absci Corp Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.92 - $6.58 $75,920 - $171,080
26,000 New
26,000 $80,000
Q4 2023

Feb 14, 2024
BUY
$1.15 - $4.79 $162,495 - $676,827
141,300 New
141,300 $593,000
Q1 2023

May 15, 2023
BUY
$1.58 - $3.41 $270,654 - $584,133
171,300 Added 133.1%
300,000 $525,000
Q4 2022

Feb 14, 2023
SELL
$2.0 - $3.58 $142,600 - $255,254
-71,300 Reduced 35.65%
128,700 $270,000
Q3 2022

Nov 14, 2022
BUY
$2.95 - $4.83 $590,000 - $966,000
200,000 New
200,000 $626,000

Others Institutions Holding ABSI

# of Institutions
128
Shares Held
59.1M
Call Options Held
255K
Put Options Held
93.6K
View Full List

About Absci Corp

ABSI Quotes by TradingView
  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $264M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email